Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BYSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 14.61M
March 31, 2026 18.41M
December 31, 2025 25.93M
September 30, 2025 29.48M
June 30, 2025 31.04M
March 31, 2025 37.10M
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021 81.65M
September 30, 2021 98.37M
June 30, 2021 82.53M
March 31, 2021 97.09M
Date Value
December 31, 2020 117.04M
September 30, 2020 39.40M
June 30, 2020 46.72M
March 31, 2020 33.50M
December 31, 2019 44.56M
September 30, 2019 34.14M
June 30, 2019 6.014M
March 31, 2019 7.845M
December 31, 2018 7.063M
September 30, 2018
June 30, 2018 25.49M
March 31, 2018 23.89M
December 31, 2017 32.83M
September 30, 2017 43.57M
June 30, 2017 51.12M
March 31, 2017 55.96M
December 31, 2016 14.91M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics